Netherlands· NL-aaef4c017ae5
Olmesartan medoxomil/Hydrochloorthiazide Krka 20 mg/25 mg filmomhulde tabletten
A olmesartan medoxomil und diuretika product containing hydrochloorthiazide + olmesartanmedoxomil, registered in Netherlands by Krka d.d., Novo mesto. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil und diuretika is registered in 12 of 19 countries.
Countries holding a registration under ATC C09DA08 (olmesartan medoxomil und diuretika), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Olmesartan medoxomil und diuretika · ATC C09DA08
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HYDROCHLOORTHIAZIDE + OLMESARTANMEDOXOMIL
- Manufacturer
- Krka d.d., Novo mesto
- Country
- Netherlands (NL)
- ATC code
- C09DA08
- ATC class
- Olmesartan medoxomil und Diuretika
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id117481
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for olmesartan medoxomil und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09DA08
Olmesartan medoxomil und diuretika, as other registers publish it.
- CanadaACH-OLMESARTAN HCTZACCORD HEALTHCARE INC
- CanadaACH-OLMESARTAN HCTZACCORD HEALTHCARE INC
- CanadaACH-OLMESARTAN HCTZACCORD HEALTHCARE INC
- CanadaAPO-OLMESARTAN/HCTZAPOTEX INC
- CanadaAPO-OLMESARTAN/HCTZAPOTEX INC
- CanadaAPO-OLMESARTAN/HCTZAPOTEX INC
- CanadaAURO-OLMESARTAN HCTZAURO PHARMA INC
- CanadaAURO-OLMESARTAN HCTZAURO PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3a6ec1b-53b9-4638-a07f-c53043115504 GET /v1/drugs/b3a6ec1b-53b9-4638-a07f-c53043115504?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117481_smpc.pdf",
"strength": null,
"atc_label": "Olmesartan Medoxomil And Diuretics",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117481",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
"MACROGOL 3000",
"MAGNESIUMSTEARAAT (E 470b)",
"POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"HYDROCHLOORTHIAZIDE",
"OLMESARTANMEDOXOMIL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117481.pdf",
"authorised_at": "2016/09/20",
"procedure_number": "DK/H/2521/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "117481",
"additional_monitoring": "N"
}See everything about olmesartan medoxomil und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.